Status:
RECRUITING
Preliminary Study on the Diagnostic Value Comparison of 18F-FAPI-04 PET/CT and PET/MR in Gastric Cancer
Lead Sponsor:
Hunan Cancer Hospital
Conditions:
Gastric Cancer
Eligibility:
All Genders
18-90 years
Brief Summary
This project aims to comprehensively analyze the diagnostic efficacy of SUVmax, SUVean, TLG, MTV, etc. in gastric cancer through 18F-FAPI-04 PET/CT imaging combined with serum tumor markers and other ...
Eligibility Criteria
Inclusion
- Age over 18 years old;
- Diagnosed as a patient with gastric cancer;
- Receive FAPI PET/CT and FDG PET/CT imaging within one week;
- Perform serum tumor marker testing one week before and after scanning
Exclusion
- History of other malignant tumors;
- Patients with severe infections, severe underlying diseases such as heart, kidney, and liver;
- Patients with contraindications for PET-CT examination, poor physical condition, and inability to tolerate the examination;
- Patients with unorganized pathology or incomplete clinical data
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06543108
Start Date
January 1 2024
End Date
December 31 2028
Last Update
August 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hunan Cancer hospital
Changsha, Hunan, China, 410000